Review
doi: 10.1016/s0952-7915(96)80080-x.
Human papillomavirus vaccines for cervical cancer
Affiliations
- PMID: 8902389
- DOI: 10.1016/s0952-7915(96)80080-x
Item in Clipboard
Review
Human papillomavirus vaccines for cervical cancer
Curr Opin Immunol.
1996 Oct.
Abstract
The association of carcinoma of the uterine cervix with human papillomavirus indicates that vaccine strategies which target the virus could be useful in the control of disease progression. Recent advances have centered on directing the immune response to prevention of infection, to virus-infected (but nontransformed) cells and to virally transformed cells, with favourable results.
Similar articles
-
[Perspectives for the development of vaccines and immunotherapy against cervico-uterine cancer].Salud Publica Mex. 1998 Jan-Feb;40(1):38-46. Salud Publica Mex. 1998. PMID: 9567657 Review. Spanish.
-
Clinical studies of human papilloma vaccines in cervical cancer.Adv Exp Med Biol. 2001;495:419-27. doi: 10.1007/978-1-4615-0685-0_61. Adv Exp Med Biol. 2001. PMID: 11774604 No abstract available.
-
HPV vaccines.Best Pract Res Clin Obstet Gynaecol. 2006 Apr;20(2):279-93. doi: 10.1016/j.bpobgyn.2005.10.011. Epub 2005 Dec 13. Best Pract Res Clin Obstet Gynaecol. 2006. PMID: 16356772 Review.
-
Human papillomavirus vaccines for the prevention and treatment of cervical cancer.Curr Opin Investig Drugs. 2004 Dec;5(12):1247-61. Curr Opin Investig Drugs. 2004. PMID: 15648945 Review.
-
HPV vaccine moves into late stage trials.Nat Med. 2001 Apr;7(4):388. doi: 10.1038/86408. Nat Med. 2001. PMID: 11283639 No abstract available.
Cited by
-
Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site.J Virol. 2001 Oct;75(20):9654-64. doi: 10.1128/JVI.75.20.9654-9664.2001. J Virol. 2001. PMID: 11559797 Free PMC article.
-
Limitations of HLA-transgenic mice in presentation of HLA-restricted cytotoxic T-cell epitopes from endogenously processed human papillomavirus type 16 E7 protein.Immunology. 2002 Aug;106(4):526-36. doi: 10.1046/j.1365-2567.2002.01442.x. Immunology. 2002. PMID: 12153516 Free PMC article.
-
Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in mice.BMC Cancer. 2014 May 24;14:367. doi: 10.1186/1471-2407-14-367. BMC Cancer. 2014. PMID: 24885328 Free PMC article.
-
A survey of the humoral immune response of cancer patients to a panel of human tumor antigens.J Exp Med. 1998 Apr 20;187(8):1349-54. doi: 10.1084/jem.187.8.1349. J Exp Med. 1998. PMID: 9547346 Free PMC article.
-
Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting.J Clin Invest. 2002 Dec;110(12):1813-22. doi: 10.1172/JCI16428. J Clin Invest. 2002. PMID: 12488431 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
